Jiangsu Simcere Pharmaceutical Co., Ltd.
Clinical trials sponsored by Jiangsu Simcere Pharmaceutical Co., Ltd., explained in plain language.
-
New eczema drug shows promise in Mid-Stage trial
Disease control Not yet recruitingThis study tests a new drug called SIM0278 in 184 adults with moderate to severe atopic dermatitis (eczema). Participants will receive one of three doses of the drug or a placebo to see if it reduces skin redness, itching, and rash. The main goal is to measure improvement in ecze…
Phase: PHASE2 • Sponsor: Jiangsu Simcere Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 13, 2026 15:59 UTC
-
New drug SIM0811 put to the test in healthy volunteers
Knowledge-focused Not yet recruitingThis early-stage study tests a new drug called SIM0811 in 56 healthy Chinese adults aged 18 to 45. Participants receive either the drug or a placebo, and researchers monitor for side effects and how the drug moves through the body. The goal is to see if the drug is safe and toler…
Phase: PHASE1 • Sponsor: Jiangsu Simcere Pharmaceutical Co., Ltd. • Aim: Knowledge-focused
Last updated May 11, 2026 20:37 UTC